| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.
|
JAMA
|
2010
|
8.53
|
|
2
|
Prophylactic catheter ablation for the prevention of defibrillator therapy.
|
N Engl J Med
|
2007
|
5.05
|
|
3
|
Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study.
|
Circulation
|
2011
|
4.95
|
|
4
|
Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239.
|
J Virol
|
2006
|
4.68
|
|
5
|
Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses.
|
Circ Arrhythm Electrophysiol
|
2009
|
3.09
|
|
6
|
Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection.
|
J Infect Dis
|
2006
|
3.04
|
|
7
|
The National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012.
|
J Am Coll Cardiol
|
2012
|
2.50
|
|
8
|
Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge.
|
J Virol
|
2009
|
2.38
|
|
9
|
The frequency and cost of complications associated with coronary artery bypass grafting surgery: results from the United States Medicare program.
|
Ann Thorac Surg
|
2008
|
2.29
|
|
10
|
Multispecific vaccine-induced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239.
|
J Virol
|
2003
|
2.14
|
|
11
|
Escape in one of two cytotoxic T-lymphocyte epitopes bound by a high-frequency major histocompatibility complex class I molecule, Mamu-A*02: a paradigm for virus evolution and persistence?
|
J Virol
|
2002
|
1.93
|
|
12
|
Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries.
|
Heart Rhythm
|
2009
|
1.82
|
|
13
|
Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition.
|
J Immunol
|
2004
|
1.81
|
|
14
|
Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators.
|
Heart Rhythm
|
2011
|
1.80
|
|
15
|
Meta-analysis of ablation of atrial flutter and supraventricular tachycardia.
|
Am J Cardiol
|
2009
|
1.77
|
|
16
|
Non-inducibility post-pulmonary vein isolation achieving exit block predicts freedom from atrial fibrillation.
|
Eur Heart J
|
2005
|
1.74
|
|
17
|
Review of the registry's fourth year, incorporating lead data and pediatric ICD procedures, and use as a national performance measure.
|
Heart Rhythm
|
2010
|
1.74
|
|
18
|
Tau truncation during neurofibrillary tangle evolution in Alzheimer's disease.
|
Neurobiol Aging
|
2004
|
1.73
|
|
19
|
Influence of clinical and procedural predictors on ventricular tachycardia ablation outcomes: an analysis from the substrate mapping and ablation in Sinus Rhythm to Halt Ventricular Tachycardia Trial (SMASH-VT).
|
J Cardiovasc Electrophysiol
|
2010
|
1.65
|
|
20
|
Early N-terminal changes and caspase-6 cleavage of tau in Alzheimer's disease.
|
J Neurosci
|
2004
|
1.48
|
|
21
|
In-hospital management of atrial fibrillation: the CHADS₂ score predicts increased cost.
|
Can J Cardiol
|
2011
|
1.46
|
|
22
|
Security and privacy qualities of medical devices: an analysis of FDA postmarket surveillance.
|
PLoS One
|
2012
|
1.40
|
|
23
|
Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation.
|
Circ Arrhythm Electrophysiol
|
2010
|
1.40
|
|
24
|
Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo.
|
J Neurochem
|
2006
|
1.39
|
|
25
|
The National ICD Registry Report: version 2.1 including leads and pediatrics for years 2010 and 2011.
|
Heart Rhythm
|
2013
|
1.39
|
|
26
|
Inducibility of atrial fibrillation with a synchronized external low energy shock post-pulmonary vein isolation predicts recurrent atrial fibrillation.
|
J Cardiovasc Electrophysiol
|
2008
|
1.38
|
|
27
|
Genital ulcers facilitate rapid viral entry and dissemination following intravaginal inoculation with cell-associated simian immunodeficiency virus SIVmac239.
|
J Virol
|
2008
|
1.36
|
|
28
|
Use of the Kansas City Cardiomyopathy Questionnaire for monitoring health status in patients with aortic stenosis.
|
Circ Heart Fail
|
2012
|
1.32
|
|
29
|
Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures.
|
J Neurointerv Surg
|
2012
|
1.28
|
|
30
|
Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry.
|
Arch Intern Med
|
2012
|
1.24
|
|
31
|
Impact of a practice guideline for patients with atrial fibrillation on medical resource utilization and costs.
|
Am J Cardiol
|
2003
|
1.22
|
|
32
|
Making inferences on treatment effects from real world data: propensity scores, confounding by indication, and other perils for the unwary in observational research.
|
BMJ
|
2013
|
1.22
|
|
33
|
Consequences of cytotoxic T-lymphocyte escape: common escape mutations in simian immunodeficiency virus are poorly recognized in naive hosts.
|
J Virol
|
2004
|
1.17
|
|
34
|
A cost-minimization analysis of the angio-seal vascular closure device following percutaneous coronary intervention.
|
Am J Cardiol
|
2007
|
1.14
|
|
35
|
Differential antigen presentation kinetics of CD8+ T-cell epitopes derived from the same viral protein.
|
J Virol
|
2008
|
1.07
|
|
36
|
Interpreting the results of cost-effectiveness studies.
|
J Am Coll Cardiol
|
2008
|
1.04
|
|
37
|
Mortality following defibrillator implantation in patients with renal insufficiency.
|
J Cardiovasc Electrophysiol
|
2006
|
1.03
|
|
38
|
A possible link between astrocyte activation and tau nitration in Alzheimer's disease.
|
Neurobiol Dis
|
2008
|
1.01
|
|
39
|
Bi-directional electrical pulmonary vein isolation as an endpoint for ablation of paroxysmal atrial fibrillation.
|
J Interv Card Electrophysiol
|
2007
|
0.99
|
|
40
|
Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: results from the NCDR.
|
Heart Rhythm
|
2014
|
0.99
|
|
41
|
Economic evaluation of bivalirudin with or without glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for early invasive management of acute coronary syndromes.
|
J Am Coll Cardiol
|
2008
|
0.94
|
|
42
|
Characteristics and outcomes of patients receiving new and replacement implantable cardioverter-defibrillators: results from the NCDR.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
0.94
|
|
43
|
Cost-effectiveness of transcatheter valvular interventions: economic challenges.
|
EuroIntervention
|
2013
|
0.94
|
|
44
|
Prevalence and predictors of off-label use of cardiac resynchronization therapy in patients enrolled in the National Cardiovascular Data Registry Implantable Cardiac-Defibrillator Registry.
|
J Am Coll Cardiol
|
2010
|
0.92
|
|
45
|
GagCM9-specific CD8+ T cells expressing limited public TCR clonotypes do not suppress SIV replication in vivo.
|
PLoS One
|
2011
|
0.92
|
|
46
|
Sex differences in hospital risk-adjusted mortality rates for Medicare beneficiaries undergoing CABG surgery.
|
Arch Intern Med
|
2008
|
0.90
|
|
47
|
Independent multicenter study of Riata and Riata ST implantable cardioverter-defibrillator leads.
|
Heart Rhythm
|
2012
|
0.90
|
|
48
|
Measurements of immune responses for establishing correlates of vaccine protection against HIV.
|
AIDS Res Hum Retroviruses
|
2011
|
0.90
|
|
49
|
Localized populations of CD8 MHC class I tetramer SIV-specific T cells in lymphoid follicles and genital epithelium.
|
PLoS One
|
2009
|
0.88
|
|
50
|
Interpreting changes in quality of life in atrial fibrillation: how much change is meaningful?
|
Am Heart J
|
2013
|
0.87
|
|
51
|
Discontinuation of rivaroxaban: filling in the gaps.
|
J Am Coll Cardiol
|
2013
|
0.87
|
|
52
|
Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudication.
|
J Vasc Interv Radiol
|
2013
|
0.86
|
|
53
|
High viremia is associated with high levels of in vivo major histocompatibility complex class I Downregulation in rhesus macaques infected with simian immunodeficiency virus SIVmac239.
|
J Virol
|
2010
|
0.85
|
|
54
|
Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation.
|
J Cardiovasc Electrophysiol
|
2011
|
0.85
|
|
55
|
Magnetic resonance imaging and cardiac devices: how safe is safe enough?
|
Ann Intern Med
|
2011
|
0.85
|
|
56
|
A reevaluation of the costs of heart failure and its implications for allocation of health resources in the United States.
|
Clin Cardiol
|
2014
|
0.83
|
|
57
|
Four evolving strategies in the emergent treatment of acute ischemic stroke.
|
Emerg Med Pract
|
2012
|
0.83
|
|
58
|
Simian immunodeficiency virus SIVmac239Deltanef vaccination elicits different Tat28-35SL8-specific CD8+ T-cell clonotypes compared to a DNA prime/adenovirus type 5 boost regimen in rhesus macaques.
|
J Virol
|
2011
|
0.83
|
|
59
|
The burden of atrial fibrillation and other cardiac arrhythmias in an employed population: associated costs, absences, and objective productivity loss.
|
J Occup Environ Med
|
2010
|
0.82
|
|
60
|
Pipeline embolization device and subsequent vessel sacrifice for treatment of a bleeding carotid pseudoaneurysm at the skull base: a case report.
|
J Neurointerv Surg
|
2012
|
0.82
|
|
61
|
The cost-effectiveness of transcatheter aortic valve replacement for nonsurgical candidates: revisionist history or the final word?
|
Circ Cardiovasc Qual Outcomes
|
2013
|
0.82
|
|
62
|
Sex differences in the relationship between amiodarone use and the need for permanent pacing in patients with atrial fibrillation.
|
Arch Intern Med
|
2007
|
0.81
|
|
63
|
Resynchronization: considering device-based cardiac therapy in older adults.
|
J Am Geriatr Soc
|
2013
|
0.80
|
|
64
|
Advances in atrial fibrillation ablation.
|
J Invasive Cardiol
|
2009
|
0.80
|
|
65
|
Economic impact to employers of treatment options for cardiac arrhythmias in the US health system.
|
J Occup Environ Med
|
2011
|
0.79
|
|
66
|
Transient hemispatial neglect after surgical resection of a right frontal lobe mass.
|
World Neurosurg
|
2011
|
0.79
|
|
67
|
Acute safety outcomes in younger and older patients with atrial fibrillation treated with catheter ablation.
|
J Interv Card Electrophysiol
|
2012
|
0.78
|
|
68
|
Cost-effectiveness of TAVR in the non-surgical population.
|
J Med Econ
|
2013
|
0.77
|
|
69
|
No additional protection against ventriculitis with prolonged systemic antibiotic prophylaxis for patients treated with antibiotic-coated external ventricular drains.
|
J Neurosurg
|
2015
|
0.77
|
|
70
|
Cost-effectiveness of everolimus- versus paclitaxel-eluting stents for patients undergoing percutaneous coronary revascularization (from the SPIRIT-IV Trial).
|
Am J Cardiol
|
2012
|
0.77
|
|
71
|
Rapid, repeated, low-dose challenges with SIVmac239 infect animals in a condensed challenge window.
|
Retrovirology
|
2014
|
0.77
|
|
72
|
An alternative Cattell-Horn-Carroll (CHC) factor structure of the WAIS-IV: age invariance of an alternative model for ages 70-90.
|
Psychol Assess
|
2012
|
0.77
|
|
73
|
Trends in US hospitalization rates and rhythm control therapies following publication of the AFFIRM and RACE trials.
|
J Cardiovasc Electrophysiol
|
2010
|
0.76
|
|
74
|
Reply: To PMID 23122802.
|
J Am Coll Cardiol
|
2013
|
0.75
|
|
75
|
Is AF Ablation Cost Effective?
|
J Atr Fibrillation
|
2010
|
0.75
|
|
76
|
Reply: To PMID 22818074.
|
J Am Coll Cardiol
|
2013
|
0.75
|
|
77
|
Global, broad, or specific cognitive differences? Using a MIMIC model to examine differences in CHC abilities in children with learning disabilities.
|
J Learn Disabil
|
2012
|
0.75
|
|
78
|
Gamma knife surgery for a hemangioma of the cavernous sinus in a child.
|
J Neurosurg Pediatr
|
2012
|
0.75
|